Skip to main content
Harrison Farber, MD, Pulmonology, Boston, MA, Tufts Medical Center


Pulmonology Boston, MA

Critical Care Medicine, Pleural Disease

Professor, Medicine, Boston University School of Medicine

Dr. Farber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Farber's full profile

Already have an account?

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1984
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1977 - 1980
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1977

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1981 - 2025
  • VA State Medical License
    VA State Medical License 1978 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2010-2013
  • Elected Member The American Society for Clinical Investigation, 1992
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations


Journal Articles

  • Serum Biomarker for Diagnostic Evaluation of Pulmonary Arterial Hypertension in Systemic Sclerosis  
    Harrison W Farber, Kari Roberts, Nicholas Hill, Robyn Domsic, Robert W Simms, BioMed Central


  • 10th International Pulmonary Hypertension Conference and Scientific Sessions 
    Pulmonary Hypertension Association, Orlando, Florida - 6/22/2012


Press Mentions

  • Pulmonary Arterial Hypertension
    Pulmonary Arterial HypertensionJune 28th, 2016

Grant Support

  • Biomarkers Of Pulmonary Complications Of Scleroderma: The Ssc-Pah AndNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
  • Oxidant State And Nitric Oxide Metabolism In The Acute Chest SyndromeNational Heart, Lung, And Blood Institute2004–2007
  • Endothelial Cell Hypoxia Tolerance: Role Of PlasmalogensNational Heart, Lung, And Blood Institute2003–2006
  • Endothelial Cell Hypoxia Associated ProteinsNational Heart, Lung, And Blood Institute1997–2000
  • Endothelial Cell Hypoxia-Associated ProteinsNational Heart, Lung, And Blood Institute1993–1996
  • Endothelial Cell Derived Neutrophil ChemoattractantsNational Heart, Lung, And Blood Institute1985–1987

Other Languages

  • French

Hospital Affiliations